AngioDynamics Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . AngioDynamics
ANGO Stock  USD 9.44  0.15  1.56%   
AngioDynamics financial statements provide useful quarterly and yearly information to potential AngioDynamics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on AngioDynamics financial statements helps investors assess AngioDynamics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting AngioDynamics' valuation are summarized below:
Gross Profit
151 M
Profit Margin
(0.78)
Market Capitalization
388.1 M
Enterprise Value Revenue
1.1011
Revenue
286.5 M
We have found one hundred twenty available fundamental signals for AngioDynamics, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to validate AngioDynamics' prevailing fundamentals against the trend between 2010 and 2025 to make sure the company can sustain itself down the road. As of the 19th of March 2025, Market Cap is likely to grow to about 348 M, while Enterprise Value is likely to drop about 156.8 M.

AngioDynamics Total Revenue

246.71 Million

Check AngioDynamics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AngioDynamics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.5 M, Interest Expense of 1.7 M or Total Revenue of 246.7 M, as well as many indicators such as Price To Sales Ratio of 0.91, Dividend Yield of 0.0 or PTB Ratio of 1.17. AngioDynamics financial statements analysis is a perfect complement when working with AngioDynamics Valuation or Volatility modules.
  
Check out the analysis of AngioDynamics Correlation against competitors.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

AngioDynamics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding30 M46.2 M35 M
Slightly volatile
Total Assets525.4 M365.3 M596.3 M
Pretty Stable
Short and Long Term Debt Total6.5 M6.8 M79.7 M
Slightly volatile
Other Current Liabilities61.5 M58.5 M26.8 M
Slightly volatile
Total Current Liabilities110.1 M104.8 M68.9 M
Slightly volatile
Property Plant And Equipment Net35.4 M47.7 M42.7 M
Pretty Stable
Accounts Payable45.6 M43.4 M26.2 M
Slightly volatile
Cash47.3 M87.5 M53.1 M
Slightly volatile
Non Current Assets Total135.9 M143.1 M420.4 M
Slightly volatile
Other Assets59.4 M56.6 M28.8 M
Slightly volatile
Long Term Debt58.7 M57.3 M79.2 M
Slightly volatile
Cash And Short Term Investments62.7 M87.5 M55.7 M
Slightly volatile
Net Receivables38.7 M50.2 M44.3 M
Pretty Stable
Common Stock Total Equity308.9 K439.3 K351.2 K
Slightly volatile
Liabilities And Stockholders Equity525.4 M365.3 M596.3 M
Pretty Stable
Non Current Liabilities Total22.9 M24.1 M99.4 M
Slightly volatile
Inventory43.6 M69.7 M52.2 M
Slightly volatile
Other Current Assets15.7 M14.9 M7.1 M
Slightly volatile
Other Stockholder Equity434.9 M695.5 M512.8 M
Slightly volatile
Total Liabilities128.9 M128.9 M168.1 M
Slightly volatile
Property Plant And Equipment Gross131.3 M125 M60.9 M
Slightly volatile
Total Current Assets153.9 M222.2 M161.1 M
Slightly volatile
Short Term Debt2.2 M2.3 M9.7 M
Slightly volatile
Intangible Assets112.1 M89 M140.2 M
Pretty Stable
Common Stock314.6 K442.8 K352 K
Slightly volatile
Property Plant Equipment34.9 M51 M43 M
Very volatile
Other Liabilities32.6 M20 M30 M
Pretty Stable
Long Term Debt Total69.2 M44.8 M87.2 M
Slightly volatile
Capital Surpluse600.4 M689.1 M556.1 M
Slightly volatile
Non Current Liabilities Other13.3 M14.5 M18.4 M
Pretty Stable
Deferred Long Term Asset Charges8.9 M9.4 M13.8 M
Slightly volatile
Short and Long Term Debt4 M4.3 M41.4 M
Slightly volatile
Net Invested Capital279.2 M189.3 M433.1 M
Slightly volatile
Net Working Capital87.1 M91.9 M96.5 M
Very volatile
Capital Stock416.2 K442.8 K381.6 K
Slightly volatile

AngioDynamics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization18.5 M31.9 M25 M
Slightly volatile
Total Revenue246.7 M349.5 M301 M
Slightly volatile
Gross Profit131.3 M177.9 M155.8 M
Slightly volatile
Other Operating Expenses599.3 M570.8 M341.9 M
Slightly volatile
Research Development21.9 M36.2 M26.5 M
Slightly volatile
Cost Of Revenue115.4 M171.6 M145.2 M
Pretty Stable
Total Operating Expenses419.2 M399.2 M192.7 M
Slightly volatile
Selling General Administrative28.3 M47.3 M31.7 M
Slightly volatile
Selling And Marketing Expenses75.9 M118.2 M81.2 M
Slightly volatile
Non Recurring30.9 M37.4 M27.5 M
Pretty Stable
Interest Income775.5 K816.3 K2.3 M
Slightly volatile
Discontinued Operations87.5 M83.4 M44.5 M
Slightly volatile
Reconciled Depreciation29.1 M31.9 M26.3 M
Slightly volatile
Extraordinary Items42 M83.4 M42.2 M
Slightly volatile

AngioDynamics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow43.7 M51.3 M48.7 M
Slightly volatile
Depreciation18.7 M31.9 M24.3 M
Slightly volatile
Capital Expenditures7.4 M6.6 M6.6 M
Very volatile
End Period Cash Flow47.3 M87.5 M53.1 M
Slightly volatile
Stock Based Compensation8 M12.1 M7.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.910.961.7496
Slightly volatile
PTB Ratio1.171.111.2476
Very volatile
Days Sales Outstanding68.0260.2355.9022
Pretty Stable
Book Value Per Share4.374.612.0974
Slightly volatile
Stock Based Compensation To Revenue0.0190.03120.0237
Slightly volatile
Capex To Depreciation0.230.240.5949
Slightly volatile
PB Ratio1.171.111.2476
Very volatile
EV To Sales0.660.691.77
Slightly volatile
Inventory Turnover2.142.222.742
Very volatile
Days Of Inventory On Hand158171140
Very volatile
Payables Turnover7.624.556.647
Pretty Stable
Sales General And Administrative To Revenue0.07880.120.1007
Slightly volatile
Research And Ddevelopement To Revenue0.07030.09330.0867
Slightly volatile
Capex To Revenue0.03980.02180.0262
Pretty Stable
Cash Per Share2.382.181.994
Pretty Stable
Days Payables Outstanding46.2383.1161.9865
Very volatile
Intangibles To Total Assets0.380.220.5521
Pretty Stable
Current Ratio4.282.443.1645
Slightly volatile
Receivables Turnover5.266.276.7655
Pretty Stable
Shareholders Equity Per Share4.374.612.0974
Slightly volatile
Debt To Equity0.02720.02590.1536
Slightly volatile
Capex Per Share0.290.170.2143
Slightly volatile
Revenue Per Share6.046.818.4302
Slightly volatile
Interest Debt Per Share0.130.14722.3112
Slightly volatile
Debt To Assets0.02030.02140.1099
Slightly volatile
Graham Number23.2222.1215.9929
Slightly volatile
Short Term Coverage Ratios5.455.745.5206
Very volatile
Operating Cycle226231196
Pretty Stable
Price Book Value Ratio1.171.111.2476
Very volatile
Days Of Payables Outstanding46.2383.1161.9865
Very volatile
Company Equity Multiplier1.461.391.3788
Pretty Stable
Long Term Debt To Capitalization0.20.130.1378
Pretty Stable
Total Debt To Capitalization0.03050.03220.1266
Slightly volatile
Debt Equity Ratio0.02720.02590.1536
Slightly volatile
Quick Ratio3.191.672.2817
Slightly volatile
Net Income Per E B T0.940.871.4958
Pretty Stable
Cash Ratio1.240.961.1625
Pretty Stable
Cash Conversion Cycle163125131
Slightly volatile
Days Of Inventory Outstanding158171140
Very volatile
Days Of Sales Outstanding68.0260.2355.9022
Pretty Stable
Price To Book Ratio1.171.111.2476
Very volatile
Fixed Asset Turnover6.26.67.4034
Pretty Stable
Debt Ratio0.02030.02140.1099
Slightly volatile
Price Sales Ratio0.910.961.7496
Slightly volatile
Asset Turnover0.681.10.5637
Slightly volatile
Gross Profit Margin0.590.5090.5327
Pretty Stable
Price Fair Value1.171.111.2476
Very volatile

AngioDynamics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap348 M228.2 M494 M
Very volatile
Enterprise Value156.8 M165.1 M482.7 M
Slightly volatile

AngioDynamics Fundamental Market Drivers

Forward Price Earnings96.1538
Cash And Short Term Investments76.1 M

AngioDynamics Upcoming Events

4th of April 2024
Upcoming Quarterly Report
View
10th of July 2024
Next Financial Report
View
29th of February 2024
Next Fiscal Quarter End
View
10th of July 2024
Next Fiscal Year End
View
30th of November 2023
Last Quarter Report
View
31st of May 2023
Last Financial Announcement
View

About AngioDynamics Financial Statements

AngioDynamics investors utilize fundamental indicators, such as revenue or net income, to predict how AngioDynamics Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-17 M-16.1 M
Total Revenue349.5 M246.7 M
Cost Of Revenue171.6 M115.4 M
Stock Based Compensation To Revenue 0.03  0.02 
Sales General And Administrative To Revenue 0.12  0.08 
Research And Ddevelopement To Revenue 0.09  0.07 
Capex To Revenue 0.02  0.04 
Revenue Per Share 6.81  6.04 
Ebit Per Revenue(0.73)(0.69)
When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:
How To Invest In AngioDynamics
Details
Is AngioDynamics Stock a good investment?
Details
What is AngioDynamics' Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of AngioDynamics Correlation against competitors.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.59)
Revenue Per Share
7.064
Quarterly Revenue Growth
(0.08)
Return On Assets
(0.06)
Return On Equity
(0.76)
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY